Skip to main content

New York, Oct. 19, 2022 (GLOBE NEWSWIRE) — Research Nester has published a detailed market report on ‘Global Drug Delivery Systems Market‘ for the forecast period, i.e. 2023– 2033 which includes the following factors:

  • Market growth over the forecast period
  • Detailed regional synopsis
  • Market segmentation
  • Growth drivers
  • Challenges
  • Key market players and their detailed profiling

Market Scope of Global Drug Delivery Systems:

Market Size Value in 2022 (Base Year) ~ USD 40,000 Million
Market Forecast Value in 223 ~ USD 75,000 Million
Growth Rate (CAGR) of  Market (Global) ~10%
Forecast Period of Drug Delivery Systems Market (Global) 2023 – 2033

Global Drug Delivery Systems Market Size:

The global drug delivery market is to garner an approximate revenue of USD 75,000 by 2033. The market growth is attributed to vaccination awareness of various diseases including hepatitis, HIV, typhoid, influenza and others, as well as, growing vaccination drive of COVID-19. The Our World in Data figures show that 3.87 million vaccinations are performed daily and that 12.69 billion doses have been administered globally. Moreover, in 2021, the World Health Organization estimates that over 80% of people worldwide had hepatitis B vaccination, nearly 71% have received Hemophilus influenza type b immunization, and nearly 80% have received polio vaccination. Furthermore, the market growth is expected to be accelerated by digitization in drug delivery. At a corporation with 5000 employees, nearly 60% of workers agree that digital drug delivery technology is essential.

Get a Sample PDF Brochure: https://www.researchnester.com/sample-request-4460

Global Drug Delivery Systems Market: Key Takeaways

  • Asia Pacific region gains the largest portion of the revenue
  • Diabetes segment to dominate the revenue graph
  • Injectable sub-segment remains prominent in the type segment

Rising Burden of Chronic Disease and Technological Advancement is to Propel the Market Growth

The growth of the global drug delivery market systems is likely to be propelled by advancement of drug delivery systems technology followed by growing burden of chronic diseases such as, diabetes, cardiovascular issues, arthritis, cancer and others. For instance, the new program, called Efficio, debuted in January 2020. It is a cloud-based management programme that can be used with SynchroMed II intrathecal drug delivery systems. With the help of this software, professionals may efficiently target the administration of their drugs to patients who are suffering from cancer pain, chronic pain, and other types of pain. Furthermore, as per the statistics of National Library of Medicine, every 3 in 5 deaths worldwide is attributed to cardiovascular problems. The World Health Organization declared cardiovascular disease as a primary reason for major share of deaths worldwide, to count the figure, around 18 million people died of any one cardiovascular issue.

For more information in the analysis of this report, visit: https://www.researchnester.com/reports/drug-delivery-systems-market/4460

Global Drug Delivery Systems Market: Regional Overview

The global drug delivery systems market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa region.

Higher Instances of Chronic Disease and Growing Vaccination Drive of COVID-19 is to Boost the North America’s Market Growth

The drug delivery systems market growth in the North America is augmented on the account of higher share of population suffering from chronic disease. Nearly 37 million individuals have diabetes in the United States and out 8.5 million people’s diabetes is still undiagnosed. Moreover, in the United States, every sixth adult has a chronic illness, and every tenth has two or more chronic conditions, according to the Centers for Disease Control and Prevention. Further, the North America’s market growth is also propelled by increased vaccination drive. About 68% of people in the United States has gone through initial phase of COVID-19 vaccination.

Asia Pacific’s Market Growth is Elevated by Rising Geriatric Population, Higher Cases of COVID-19 and Chronic Disease

The market growth in the Asia Pacific region is boosted by growing geriatric population followed by rising number of COVID patients and people suffering with chronic disease. Japan is known as the oldest country of the world, in 2020, around 28% of the total Japanese population is of 65 years or above. Furthermore, the rising COVID-19 patients is to influence the market growth, from January 2020 to October 2022, there were over 40 million confirmed cases of COVID-19, in India. Additionally, the burden of chronic disease is rapidly rising in the Asia Pacific, out of total 40 million chronic cases worldwide, around 8 million are attributed to Asia. Moreover, nearly 55% deaths in Southeast Asia is due to chronic diseases.

Get a Sample PDF of Drug Delivery Systems Market Report@ https://www.researchnester.com/sample-request-4460

The study further incorporates Y-O-Y growth, demand & supply and forecast future opportunity in:

  • North America (U.S., Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe)
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific)
  • Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).

Global Drug Delivery Systems Market, Segmentation by Type

  • Transdermal
  • Inhalation
  • Injectable
  • Others

By type, the injectable segment, injections are highly used for the HIV, hepatitis, cancer and others. Therefore, higher prevalence of these disease is to propel the growth of the segment. Around 296 million people are living with Hepatitis-B and nearly 58 million individuals have Hepatitis-C, as per the report of the Centers for Disease Control and Prevention. Nearly 38 million people were suffering from HIV in 2020. Furthermore, the increased vaccination drive is to boost the market growth. As of August 2022, nearly 171 million Covid-19 vaccines were dispersed in Russia.

For more insights on the market share of various regions: https://www.researchnester.com/sample-request-4460

Global Drug Delivery Systems Market, Segmentation by Device Type

  • Conventional
  • Advanced                                                                                              

Global Drug Delivery Systems Market, Segmentation by Indication

  • Diabetes
  • Cardiovascular Disease
  • Multiple Sclerosis
  • Asthma & COPD

On the basis of indication, the diabetes segment is to garner the highest revenue by the end of 2033. The segment growth is attributed to higher cases of diabetes in the world. As per the statistics of the World Health Organization, around 422 million people are living with diabetes worldwide. Patient with type 1 diabetes needs insulin injection periodically. The higher demand of insulin injections is to boost the market growth. Globally, around 150-200 million patients required insulin therapy.

Global Drug Delivery Systems Market, Segmentation by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

Few of the well-known market leaders in the global drug delivery systems market that are profiled by Research Nester are BD (Becton, Dickinson and Company), Gerreshelmer AG, Baxter, Nemara, Kindeva Drug Delivery, West Pharmaceutical Services Inc., Ypsomed, Medtronic, E3D Elcam Drug Delivery Devices, AstraZeneca, Merck KGaAand others.

Do You Have Any Query Or Specific Requirement?

Submit Request for Proposal

Recent Developments in the Drug Delivery Systems Market

  • February 2022, Abbott announces the partnership with primary healthy-tech companies involving, Sugar.fit, healthifyme, Fitterfly, BeatO, PharmEasy, GOQii, 1 MG, and Zyla Health. By this collaboration, Abbott aim to deploy glucose monitoring solution to 8 million people with diabetes. Moreover, the Abbott’s Freestyle Libre allows people to check the glucose reading more frequently, it also offers advanced technology for the management of the diabetes which is expected to give better outcomes and reduces complications.
  • April 2021, Nipro Pharma Corporation announced new finding which is certainly to elaborate Nipro’s product portfolio. The Nipro D2F prefilled syringes are compatible with Schreiner MediPharm Needle-Trap of Schreiner MediPharm. Needle trap is safe and easy to use and it save cost owing to its unique design with compact body. The complete activation of the device is confirmed wither by sound or by visuals. Furthermore, it is made in a way which can be easily integrated in the existing manufacturing process

Explore Our Recent Related Reports:

COPD Therapeutics Market Analysis by Drug Class (Bronchodilators, Steroids, Phosphodiesterase-4 Inhibitors, Theophylline, Antibiotics, Oral, and Inhalation); by Type (Chronic Bronchitis, and Emphysema); by Age Group (Below 5 years, 5-14 years, 15-60 years, and Above 60 years); and by End User (Hospitals, Private Clinics, and Outpatient Departments) – Global Supply & Demand Analysis & Opportunity Outlook 2022-2031
Hospital Beds and Supporting Equipment Market Analysis by Product (Bed and Other Accessories); by Facility (Home Care, Critical, Curative, Long-Term, Bariatric, and Others); by Technology (Manual and Power); and by End-User (Rehabilitation Centers, Hospitals, Nursing Homes, and Others)– Global Supply & Demand Analysis & Opportunity Outlook 2022-2031
Clinical Trials Research Market Analysis by Phase (I, II, III, and IV); by Study Design (Expanded, Interventional, and Observational Study); and by Application (Cardiology, Oncology, Dermatology, Ophthalmology, and Autoimmune Diseases) – Global Supply & Demand Analysis & Opportunity Outlook 2022-2031
Cardiac Output Monitoring Devices Market Analysis by Product (Consumables & Accessories, and Devices); by Type (Invasive, and Non- invasive); by Technology (Pulmonary Artery Catheter, Lithium Dilution Technique, Thermodilution Pulse Contour Analysis Technique, Arterial Waveform Analysis Technique, Doppler, and Others); and by End-User (Hospitals, Ambulatory Surgical Centers, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2022-2031
Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market Analysis by Treatment Type {BPH Devices (Transurethral RF Thermal Therapy, Suture Base Implant, and Others), and BPH Drugs (Alpha Blocker, Muscarinic Receptor Antagonist, 5-Alpha Reductase Inhibitors)}; and by Distribution Channels (Online, Pharmacies, and Institutional Sales), – Global Supply & Demand Analysis & Opportunity Outlook 2022-2031

About Research Nester

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919

For More Update Follow: – LinkedIn | Twitter | Facebook | Xing



Read the original article

Leave a Reply